SENIOR MANAGEMENT

• Wayne Phillips CEO
• Market research UK
  INTERNATIONAL MARKET RESEARCH
  • Fabrice Allum: Board Director
  • Matthew Brooks: Director, Strategic MR
  • Anna Garofalo: Director, Strategic MR
  • Bridget Pumfrey: Director, Strategic MR
  • Sean Davies: Director, Strategic MR
  • Charlotte Savege: Director
  • Barry Crook: Director
  • Amanda Siebols: Research Consultant
• Market Research US
  INTERNATIONAL & US DOMESTIC
  MARKET RESEARCH
  • Jim Goldenberg: President
  • Thomas Hartford (T.H.) Kern: Senior Vice President, Strategic MR
  • Sally Davis: Senior Vice President,
    Strategic MR
    
  • Margie Sherr: Senior Vice President,
    Strategic MR
    
  • Andrea Stoltz: VP, Project Management
  • Rebekkah Carney: MIM VP, Medtech Market Research
  • Carolyn Ivins: Vice President
• Market Access and Consulting UK
  • Mike Mallinson: Managing Director
  • Shrinivas Rao Mukku: Lead Consultant, Global P&R
  • Robert White: Consultant
  • Enrico de Nigris: Consultant
  • Graeme Roberts: Consultant
  • Anna Gannedahl: Consultant
  • Henry Dummett: Consultant [Emerging Markets]
  • Ben Shankland: Consultant [Emerging Markets]
• Market Access and Consulting US
  • Michael Rizzo: Vice President
  • Caryn A. Zieses: Senior Consultant

Michael C. Rizzo

Vice President, Double Helix Consulting US

mrizzo@dhelixc.com
Tel: 646 873 6938    Fax: 646 873 6943

Mike Rizzo has extensive experience in assessing the impact of payers, physicians, patients, and intermediaries on pricing, access, and reimbursement for small molecule and specialty products. He has led client engagements in stakeholder and access risk assessment, value proposition development and messaging, pricing and contracting strategy, product positioning, pull-through, and internal and external training. His expertise spans multiple therapeutic areas including oncology, mental health, inflammatory disease, pain, cardiovascular disease, diabetes, infectious disease, women's health, and neurodegenerative disease.

Before joining Double Helix, Mike led project engagements with Campbell Alliance's managed markets practice. He was also a consultant with Charles River Associates' pharmaceuticals practice, the Pharmaceutical Research and Manufacturers Association (PhRMA), the Lombardi Cancer Research Center at Georgetown University, and The Institute for Genomic Research (TIGR). He holds an MBA from the College of William and Mary, a Master's of Public Policy from Georgetown University, and a BS in Biology from James Madison University.